Author:
Yan Lijiao,Hu Jiale,Yu Zeyu,Li Shelly-Anne,Graham Karen,Scott Sarah E.,Shen Chen,Jin Xuejing,Liu Jianping
Abstract
Abstract
Objective
To understand developers’ perception of patient (versions of) guidelines (PVGs), and identify challenges during the PVG development, with the aim to inform methodological guidance for future PVG development.
Methods
We used a descriptive qualitative design. Semi-structured interviews were conducted virtually from December 2021 to April 2022, with a purposive sampling of 12 PVG developers from nine teams in China. Conventional and directed content analysis was used for data analysis.
Results
The interviews identified PVG developers’ understanding of PVGs, their current practice experience, and the challenges of developing PVGs. Participants believed PVGs were a type of health education material for patients; therefore, it should be based on patient needs and be understandable and accessible. Participants suggested that PVGs could be translated/adapted from one or several clinical practice guidelines (CPG), or developed de novo (i.e., the creation of an entirely new PVG with its own set of research questions that are independent of existing CPGs). Participants perceived those existing methodological guidelines for PVG development might not provide clear instructions for PVGs developed from multiple CPGs and from de novo development. Challenges to PVG development include (1) a lack of standardized and native guidance on developing PVGs; (2) a lack of standardized guidance on patient engagement; (3) other challenges: no publicly known and trusted platform that could disseminate PVGs; concerns about the conflicting interests with health professionals.
Conclusions and practice implications
Our study suggests clarifying the concept of PVG is the primary task to develop PVGs and carry out related research. There is a need to make PVG developers realize the roles of PVGs, especially in helping decision-making, to maximize the effect of PVG. It is necessary to develop native consensus-based guidance considering developers’ perspectives regarding PVGs.
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Karen G, Corinna S, Nancy S. How to develop information from guidelines for patients and the public. 2021. In: GIN PUBLIC toolkit [Internet]. Available from: https://g-i-n.net/wp-content/uploads/2022/01/Toolkit-combined.pdf. Accessed 20 Dec. 2022
2. van der Weijden T, Pieterse AH, Koelewijn-van Loon MS, Knaapen L, Légaré F, Boivin A, et al. How can clinical practice guidelines be adapted to facilitate shared decision making? A qualitative key-informant study. BMJ Qual Saf. 2013;22(10):855–63.
3. SIGN. Patient Publications. Available from: https://www.sign.ac.uk/patient-and-public-involvement/patient-publications/. Accessed 20 Dec. 2022
4. US Preventive Services Task Force. Information for consumers. Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/information-for-consumers?SORT=T&PAGE=7. Accessed 17 Jan. 2022
5. Brignardello-Petersen R, Carrasco-Labra A, Guyatt GH. How to interpret and use a clinical Practice Guideline or recommendation: users’ Guides to the Medical Literature. JAMA. 2021;326(15):1516–23.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献